ranolazine has been researched along with Pituitary Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, BS; Hsu, TI; Lo, YC; Peng, H; Wu, SN | 1 |
1 other study(ies) available for ranolazine and Pituitary Neoplasms
Article | Year |
---|---|
Effects of ranolazine, a novel anti-anginal drug, on ion currents and membrane potential in pituitary tumor GH(3) cells and NG108-15 neuronal cells.
Topics: Acetanilides; Action Potentials; Angina Pectoris; Animals; Calcium Channels, L-Type; Cell Line; Cell Line, Tumor; Humans; Ion Channel Gating; Ion Transport; Membrane Potentials; Neurons; Patch-Clamp Techniques; Piperazines; Pituitary Neoplasms; Potassium Channels, Inwardly Rectifying; Ranolazine; Rats; Sodium Channels | 2009 |